Moreover, TGFβ activates the AP-1 pathway leading the production of c-Jun and JunB, respectively in epidermal keratinocytes and dermal fibroblasts (163), known to be involved in the process of phenotype switching and BRAF inhibitor resistance in melanoma (Table 2) (49, 51). The gene discussed is TGFB1; the disease is melanoma.